Marijuana-Based Drug Nears Approval for Childhood Epilepsy
Natural Society
On September 26, a marijuana-based childhood epilepsy drug took a step closer to winning approval when its maker announced promising phase 3 clinical trial results. [1]
Justin Gover, CEO of the British biotech company GW Pharmaceuticals, said that the children participating in the trial had previously tried 10 other anti-epileptic drugs. Despite using the medication, the young participants still experienced 3 seizures a day, approximately 90 a month. Said Gover:
“The impact that we have had that we have shown today is a hugely important potential breakthrough in the treatment of the condition called Lennox-Gastaut syndrome.”
Epidiolex is a drug made with pharmaceutical cannabidiol (CBD). The drug helps treat Lennox-Gastaut syndrome, as well as Dravet syndrome. Cannabidiol oil has been shown in past studies to reduce – and halt – other forms of epileptic seizures. [2]
Read: Marijuana Compound Shows Promise in Helping Kids with Dravet Syndrome
CBD does not cause the “high” associated with THC, the psychoactive substance in marijuana, but shows great promise in treating central nervous system disorders, according to Gover. He believes the drug could also be useful in treating a range of other conditions, including schizophrenia and behavioral disorders.
Epidiolex does have some side effects, however. Some of the children experienced drowsiness, decreased appetite, diarrhea, and vomiting.
The phase 3 clinical trial results revealed that patients taking 20 mg of Epidiolex had a 42% reduction in seizures versus a 17% reduction for those on placebo.
Gover boasted:
“The good news is this is actually the third positive trial within the field of treatment resistant childhood onset epilepsy that we have reported results for in the last six months.” [1]
GW Pharmaceuticals said it plans to file a new drug application with the U.S. Food and Drug Administration (FDA) in the first half of next year.
The company, which grows its own cannabis plants to study the ingredients and then synthesizes it into medication, already has 1 product on the market called Sativex – a mouth spray to treat muscle spasms associated with multiple sclerosis (MS).
No FDA-approved treatments for Dravet syndrome currently exists. Patients with the condition frequently experience prolonged and severe seizures early in life, as well as developmental delays.
Gover said:
“There’s remarkable consistency in the data here with what we’ve seen in the previous trial results. That will help us make our case to the FDA.” [2]
Sources:
[1] CNBC
[2] Fortune
University of Alabama at Birmingham
Source: http://naturalsociety.com/marijuana-based-childhood-epilepsy-drug-nears-approval-1093/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Please Help Support BeforeitsNews by trying our Natural Health Products below!
Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST
Order by Phone at 866-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST
Order by Phone at 866-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST
Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!
HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation.
Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.
MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser! Cleans out toxic buildup with oxygen!
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover - Reduces Smart Meter radiation by 96%! (See Video).